Literature DB >> 19631276

Dysbindin modulates brain function during visual processing in children.

A Mechelli1, E Viding, A Kumar, W Pettersson-Yeo, P Fusar-Poli, S Tognin, M C O'Donovan, P McGuire.   

Abstract

Schizophrenia is a neurodevelopmental disorder, and risk genes are thought to act through disruption of brain development. Several genetic studies have identified dystrobrevin binding protein 1 (DTNBP1, also known as dysbindin) as a potential susceptibility gene for schizophrenia, but its impact on brain function is poorly understood. It has been proposed that DTNBP1 may be associated with differences in visual processing. To test this, we examined the impact on visual processing in 61 healthy children aged 10-12 years of a genetic variant in DTNBP1 (rs2619538) that was common to all schizophrenia associated haplotypes in an earlier UK-Irish study. We tested the hypothesis that carriers of the risk allele would show altered occipital cortical function relative to noncarriers. Functional Magnetic Resonance Imaging (fMRI) was used to measure brain responses during a visual matching task. The data were analysed using statistical parametric mapping and statistical inferences were made at p<0.05 (corrected for multiple comparisons). Relative to noncarriers, carriers of the risk allele had greater activation in the lingual, fusiform gyrus and inferior occipital gyri. In these regions DTNBP1 genotype accounted for 19%, 20% and 14% of the inter-individual variance, respectively. Our results suggest that that genetic variation in DTNBP1 is associated with differences in the function of brain areas that mediate visual processing, and that these effects are evident in young children. These findings are consistent with the notion that the DTNBP1 gene influences brain development and can thereby modulate vulnerability to schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631276     DOI: 10.1016/j.neuroimage.2009.07.030

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  7 in total

Review 1.  Cell biology of the BLOC-1 complex subunit dysbindin, a schizophrenia susceptibility gene.

Authors:  Ariana P Mullin; Avanti Gokhale; Jennifer Larimore; Victor Faundez
Journal:  Mol Neurobiol       Date:  2011-04-26       Impact factor: 5.590

2.  Gene dosage in the dysbindin schizophrenia susceptibility network differentially affect synaptic function and plasticity.

Authors:  Ariana P Mullin; Madhumala K Sadanandappa; Wenpei Ma; Dion K Dickman; Krishnaswamy VijayRaghavan; Mani Ramaswami; Subhabrata Sanyal; Victor Faundez
Journal:  J Neurosci       Date:  2015-01-07       Impact factor: 6.167

3.  Mutations in the BLOC-1 subunits dysbindin and muted generate divergent and dosage-dependent phenotypes.

Authors:  Jennifer Larimore; Stephanie A Zlatic; Avanti Gokhale; Karine Tornieri; Kaela S Singleton; Ariana P Mullin; Junxia Tang; Konrad Talbot; Victor Faundez
Journal:  J Biol Chem       Date:  2014-04-08       Impact factor: 5.157

4.  The schizophrenia susceptibility gene DTNBP1 modulates AMPAR synaptic transmission and plasticity in the hippocampus of juvenile DBA/2J mice.

Authors:  Ian J Orozco; Peter Koppensteiner; Ipe Ninan; Ottavio Arancio
Journal:  Mol Cell Neurosci       Date:  2013-12-07       Impact factor: 4.314

5.  The effects of a DTNBP1 gene variant on attention networks: an fMRI study.

Authors:  Markus Thimm; Axel Krug; Thilo Kellermann; Valentin Markov; Sören Krach; Andreas Jansen; Klaus Zerres; Thomas Eggermann; Tony Stöcker; N Jon Shah; Markus M Nöthen; Marcella Rietschel; Tilo Kircher
Journal:  Behav Brain Funct       Date:  2010-09-16       Impact factor: 3.759

6.  Dysbindin Deficiency Modifies the Expression of GABA Neuron and Ion Permeation Transcripts in the Developing Hippocampus.

Authors:  Jennifer Larimore; Stephanie A Zlatic; Miranda Arnold; Kaela S Singleton; Rebecca Cross; Hannah Rudolph; Martha V Bruegge; Andrea Sweetman; Cecilia Garza; Eli Whisnant; Victor Faundez
Journal:  Front Genet       Date:  2017-03-10       Impact factor: 4.599

7.  Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7.

Authors:  Giovanni Luca Romano; Chiara Bianca Maria Platania; Gian Marco Leggio; Sebastiano Alfio Torrisi; Salvatore Giunta; Salvatore Salomone; Michele Purrello; Marco Ragusa; Cristina Barbagallo; Frank J Giblin; Rosa Mastrogiacomo; Francesca Managò; Maurizio Cammalleri; Francesco Papaleo; Filippo Drago; Claudio Bucolo
Journal:  Sci Rep       Date:  2020-03-04       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.